Target intelligence / Profile preview

Plasmodium falciparum digestive vacuole (DV)

Target
DV
Molecular classification
Organelle (specialized lysosome), Aspartic proteases (plasmepsins), Cysteine proteases (falcipains), Chloroquine resistance transporter (PfCRT), Multidrug resistance transporter 1 (PfMDR1), Amino acid transporter (PfAAT1), Big Vacuolar Anion Channel (BVAC)
01

Overview

The Plasmodium falciparum digestive vacuole is a lysosome-like acidic organelle that is essential for parasite survival within human erythrocytes. Through endocytosis of host cell hemoglobin, the parasite delivers it to the DV, where sequential action of proteases (mainly plasmepsins and falcipains) breaks it down to small peptides and amino acids, which are then exported for parasite use. The DV environment also enables detoxification of heme by crystallizing it into hemozoin. The DV membrane contains multiple transporters (PfCRT, PfMDR1, PfAAT1) and an identified large conductance anion channel (BVAC), playing roles in solute movement, drug resistance, and vacuole homeostasis. The DV is the main site of action for antimalarial drugs like chloroquine and artemisinin; resistance mechanisms often involve mutations in vacuolar transporters. The organelle’s critical functions in nutrient acquisition and detoxification make it a central therapeutic target in malaria drug development.

Other names
food vacuoleDV
02

Mechanism of action

Inhibition of hemozoin formation (chloroquine) - Free radical generation leading to organelle damage (artemisinin) - Protease inhibition—blocking hemoglobin digestion (plasmepsin and falcipain inhibitors) - Disruption of ion homeostasis or membrane transport (targeting anion channels or transporters)

03

Biological functions

Hemoglobin digestionAmino acid salvageHeme detoxification (conversion to hemozoin)Drug transport and resistance
04

Disease associations

Infection (malaria)Drug resistance in malaria (e.g. chloroquine resistance)
05

Safety considerations

Drug resistance due to mutations in DV transporters (e.g. PfCRT and PfMDR1)Potential for off-target toxicity with protease inhibitorsToxicity from accumulation of free heme if hemozoin formation is disrupted
06

Interacting drugs

Chloroquine

5 more in the full profile.

07

Biomarkers

Expression/mutation of PfCRT (chloroquine resistance)Expression/mutation of PfMDR1Hemozoin accumulation and composition

Beyond the preview

Go deeper on Plasmodium falciparum digestive vacuole (DV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum digestive vacuole (DV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call